Key result
Solid malignancies linked to ~97% higher VTE incidence in hospitalized patients versus non-cancer patients.
Why the study?
Venous thromboembolism occurs more frequently in cancer patients than in the general population.
Population
Patients with solid tumor complicated with VTE admitted to a single cancer center
Design
10-year retrospective cross-sectional study
Authors
Loading...
Incidence data in hospitalized solid-tumor patients supports VTE vigilance; leaves open prospective validation of risk models.
Cross-Sectional (n=45,315)
No
Absolute Event Rate: 1.79% vs 0.91%
VTE occurrence in cancer patients is closely related to tumor stage, site, catheterization, and anti-neoplasm therapy, with upper extremity DVT being particularly common and associated with central venous catheters.
Peng et al. (2021) conducted a cross-sectional in Solid malignancies (n=45,315). Solid malignancies vs. Hospitalized non-cancer patients was evaluated on Incidence of venous thromboembolism (VTE). Hospitalized patients with solid malignancies had a venous thromboembolism incidence of 1.79%, which was approximately twice the incidence observed in hospitalized non-cancer patients (0.91%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: